Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

New-look heart failure treatment shows early promise
Reducing the activity of a specific protein could provide significant relief for many heart failure patients.
Vascular surgeon indicted for murder of ex-wife and her husband
Michael McKee is accused of making the journey from Illinois to Ohio and then shooting the two victims in their home on Dec. 30. He was arrested after surveillance footage showed his car at the scene before and after the murders.
Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD
Postprocedural gradients can tell cardiologists a lot about a patient's long-term risk of structural valve deterioration.
Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent
The CGuard Prime carotid stent system from InspireMD was approved by the FDA in 2025. These data confirm the device's ability to reduce a patient's stroke risk during treatment.
FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure
Vapor 2000 and Vapor 3000 devices manufactured by Draegar were improperly cleaned after parts were soldered on, meaning toxic metals could mix with medical gases. Due to the high risk posed to patient health, this recall has earned the FDA’s most serious designation.

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.

Cardiologist Carlos Collet takes new leadership role with CRF

Collet, known globally for his dedication to innovation, is the organization's new director of cardiovascular imaging, physiology and translational therapeutics.

Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M

The FDA-cleared EluPro bioenvelope delivers two antibiotics to patients over an extended period of time after they receive an implantable pacemaker or defibrillator to cut infection rates.

diet nuts legumes vegetables vegan vegetarian plant-based

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.

Mayo Clinic announces cuts and closures, citing healthcare staffing woes

Many Mayo Clinic patients in rural Minnesota may need to travel or rely on telehealth, as six locations are closing for good before the end of the year.

stroke brain dementia alzheimer's puzzle mental health

Iron load on imaging could signal impending cognitive decline in asymptomatic patients

Using an advanced MRI technique, experts were able to measure tissue susceptibility and detect subtle variances in iron levels throughout different regions of the brain associated with memory.

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

TAVR still a safe option for patients with nickel allergies

More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.

Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.

Clinical

New-look heart failure treatment shows early promise

Vascular surgeon indicted for murder of ex-wife and her husband

Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD

Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent

FDA announces Class I recall on anesthesia vaporizers due to risk of chemical exposure